Park, E.-J.; Park, H.-J.; Kim, K.-W.; Suh, C.-H.; Yoo, C.; Chae, Y.-K.; Tirumani, S.H.; Ramaiya, N.H.
Efficacy of Immune Checkpoint Inhibitors against Advanced or Metastatic Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis. Cancers 2022, 14, 794.
https://doi.org/10.3390/cancers14030794
AMA Style
Park E-J, Park H-J, Kim K-W, Suh C-H, Yoo C, Chae Y-K, Tirumani SH, Ramaiya NH.
Efficacy of Immune Checkpoint Inhibitors against Advanced or Metastatic Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis. Cancers. 2022; 14(3):794.
https://doi.org/10.3390/cancers14030794
Chicago/Turabian Style
Park, Eun-Joo, Hyo-Jung Park, Kyung-Won Kim, Chong-Hyun Suh, Changhoon Yoo, Young-Kwang Chae, Sree Harsha Tirumani, and Nikhil H. Ramaiya.
2022. "Efficacy of Immune Checkpoint Inhibitors against Advanced or Metastatic Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis" Cancers 14, no. 3: 794.
https://doi.org/10.3390/cancers14030794
APA Style
Park, E. -J., Park, H. -J., Kim, K. -W., Suh, C. -H., Yoo, C., Chae, Y. -K., Tirumani, S. H., & Ramaiya, N. H.
(2022). Efficacy of Immune Checkpoint Inhibitors against Advanced or Metastatic Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis. Cancers, 14(3), 794.
https://doi.org/10.3390/cancers14030794